Chris Stevo | Senior Vice President and Chief Investor Relations Officer |
Albert Bourla | Chairman and Chief Executive Officer |
Frank D’Amelio | Chief Financial Officer |
Mikael Dolsten | President of Worldwide Research and Development in Medical |
Angela Hwang | Group President Pfizer Biopharmaceuticals Group |
Aamir Malik | Chief Business Innovation Officer |
Doug Lankler | General Counsel |
Geoff Meacham | Bank of America Securities |
Rohit Bansal | Wells Fargo |
Evan Seigerman | BMO Capital Markets |
Umer Raffat | Evercore ISI |
Louise Chen | Cantor |
Steve Scala | Cowen |
Tim Anderson | Wolfe Research |
Andrew Baum | Citi |
Chris Schott | JP Morgan |
Chris Shibutani | Goldman Sachs |
Vamil Divan | Mizuho Securities |
Kerry Holford | Berenberg |
Carter Gould | Barclays |
Good day, everyone, and welcome to Pfizer's Fourth Quarter 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.